Mechanistic Insights to Weight Loss Maintenance Through SGLT2 Inhibitors
Conditions: Obesity; Weight Loss Interventions: Drug: Empagliflozin Arm; Other: Control Arm; Other: Exercise capacity VO2 maximum determination; Other: Exercise Challenge Sponsor: University of Alabama at Birmingham Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Eating Disorders & Weight Management | Obesity | Research | SGLT2 Inhibitors | Sports Medicine | Weight Loss